Omicron infection increases IgG binding to spike protein of predecessor variants. Issue 2 (9th January 2023)
- Record Type:
- Journal Article
- Title:
- Omicron infection increases IgG binding to spike protein of predecessor variants. Issue 2 (9th January 2023)
- Main Title:
- Omicron infection increases IgG binding to spike protein of predecessor variants
- Authors:
- Mahalingam, Gokulnath
Periyasami, Yogapriya
Arjunan, Porkizhi
Subaschandrabose, Rajesh K.
Mathivanan, Tamil V.
Mathew, Roshlin S.
Devi, Ramya K. T.
Premkumar, Prasanna S.
Muliyil, Jayaprakash
Srivastava, Alok
Moorthy, Mahesh
Marepally, Srujan - Abstract:
- Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission in India in 2020–2022 was driven predominantly by Wild (Wuhan‐Hu‐1 and D614G), Delta, and Omicron variants. The aim of this study was to examine the effect of infections on the humoral immune response and cross‐reactivity to spike proteins of Wuhan‐Hu‐1, Delta, C.1.2., and Omicron. Residual archival sera ( N = 81) received between January 2020 and March 2022 were included. Infection status was inferred by a positive SARS‐CoV‐2 RT‐PCR and/or serology (anti‐N and anti‐S antibodies) and sequencing of contemporaneous samples ( N = 18) to infer lineage. We estimated the levels and cross‐reactivity of infection‐induced sera including Wild, Delta, Omicron as well as vaccine breakthrough infections (Delta and Omicron). We found an approximately two‐fold increase in spike‐specific IgG antibody binding in post‐Omicron infection compared with the pre‐Omicron period, whilst the change in pre‐ and post‐Delta infections were similar. Further investigation of Omicron‐specific humoral responses revealed primary Omicron infection as an inducer of cross‐reactive antibodies against predecessor variants, in spite of the weaker degree of humoral response compared to Wuhan‐Hu‐1 and Delta infection. Intriguingly, Omicron vaccine‐breakthrough infections when compared with primary infections, exhibited increased humoral responses against RBD (7.7‐fold) and Trimeric S (Trimeric form of spike protein) (34.6‐fold) inAbstract: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) transmission in India in 2020–2022 was driven predominantly by Wild (Wuhan‐Hu‐1 and D614G), Delta, and Omicron variants. The aim of this study was to examine the effect of infections on the humoral immune response and cross‐reactivity to spike proteins of Wuhan‐Hu‐1, Delta, C.1.2., and Omicron. Residual archival sera ( N = 81) received between January 2020 and March 2022 were included. Infection status was inferred by a positive SARS‐CoV‐2 RT‐PCR and/or serology (anti‐N and anti‐S antibodies) and sequencing of contemporaneous samples ( N = 18) to infer lineage. We estimated the levels and cross‐reactivity of infection‐induced sera including Wild, Delta, Omicron as well as vaccine breakthrough infections (Delta and Omicron). We found an approximately two‐fold increase in spike‐specific IgG antibody binding in post‐Omicron infection compared with the pre‐Omicron period, whilst the change in pre‐ and post‐Delta infections were similar. Further investigation of Omicron‐specific humoral responses revealed primary Omicron infection as an inducer of cross‐reactive antibodies against predecessor variants, in spite of the weaker degree of humoral response compared to Wuhan‐Hu‐1 and Delta infection. Intriguingly, Omicron vaccine‐breakthrough infections when compared with primary infections, exhibited increased humoral responses against RBD (7.7‐fold) and Trimeric S (Trimeric form of spike protein) (34.6‐fold) in addition to increased binding of IgGs towards previously circulating variants (4.2 ‐ 6.5‐fold). Despite Delta breakthrough infections showing a higher level of humoral response against RBD (2.9‐fold) and Trimeric S (5.7‐fold) compared to primary Delta sera, a demonstrably reduced binding (36%–49%) was observed to Omicron spike protein. Omicron vaccine breakthrough infection results in increased intensity of humoral response and wider breadth of IgG binding to spike proteins of antigenically‐distinct, predecessor variants. … (more)
- Is Part Of:
- Journal of medical virology. Volume 95:Issue 2(2023)
- Journal:
- Journal of medical virology
- Issue:
- Volume 95:Issue 2(2023)
- Issue Display:
- Volume 95, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 95
- Issue:
- 2
- Issue Sort Value:
- 2023-0095-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2023-01-09
- Subjects:
- Breakthrough infection -- Delta -- Humoral immunity -- Immune responses -- Omicron -- SARS coronavirus -- SARS‐CoV‐2 spike variants
Virology -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9071 ↗
http://www.interscience.wiley.com/jpages/0146-6615 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmv.28419 ↗
- Languages:
- English
- ISSNs:
- 0146-6615
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5017.095000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26053.xml